Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma.
Leukemia., Jun;25(6):1026-35 (2011)
Once- versus twice-weekly bortezomib induction therapy with CyBorD in newly diagnosed multiple myeloma.
Blood., Apr;115(16):3416-7 (2010)
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.
Leukemia., Dec;23(12):2210-21 (2009)
Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial.
Leukemia., Jul;23(7):1337-41 (2009)
Genetic aberrations and survival in plasma cell leukemia.
Leukemia., May;22(5):1044-52 (2008)
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
Leukemia., Mar;21(3):529-34 (2007)
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma.
Leukemia., Nov;20(11):2034-40 (2006)
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.
Blood., Oct;108(8):2755-63 (2006)
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.
Leukemia., May;20(5):807-13 (2006)
Ploidy status rarely changes in myeloma patients at disease progression.
Leuk. Res., Mar;30(3):266-71 (2006)
The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.
Blood., Nov;92(9):3025-34 (1998)
CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements.
Blood., Mar;89(5):1824-33 (1997)
Dysregulation of c-myc in multiple myeloma.
Curr. Top. Microbiol. Immunol., 224:277-82 (1997)
Selective expression of one c-myc allele in two human myeloma cell lines.
Cancer Res., Oct;56(19):4370-3 (1996)
Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.
Blood., Jul;88(2):674-81 (1996)
Genes expressed selectively in murine and human plasma cell neoplasms.
Curr. Top. Microbiol. Immunol., 194:57-61 (1995)
The blood B-cells and bone marrow plasma cells in patients with multiple myeloma share identical IgH rearrangements.
Curr. Top. Microbiol. Immunol., 194:17-24 (1995)
Sequence and expression of murine cDNAs encoding Xlr3a and Xlr3b, defining a new X-linked lymphocyte-regulated Xlr gene subfamily.
Gene., Dec;150(2):345-50 (1994)
A murine cDNA encodes a pan-epithelial glycoprotein that is also expressed on plasma cells.
J. Immunol., Jan;148(2):590-6 (1992)
Genes expressed selectively in plasmacytomas: markers of differentiation and transformation.
Curr. Top. Microbiol. Immunol., 182:223-8 (1992)
Identification of consensus genes expressed in plasmacytomas but not B lymphomas.
Curr. Top. Microbiol. Immunol., 166:141-7 (1990)